Gabriel Brisou

机构：Assistance Publique Hôpitaux de Marseille, Délégation Provence et Corse, Institut Paoli-Calmettes · ORCID：0000-0003-0771-683X

发表论文 37 篇 · 总被引 101 次 · h-index 5

代表论文

• Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy (2024 · Blood Advances · 被引 16)
• Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry (2025 · HemaSphere · 被引 15)
• Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry (2025 · Blood Advances · 被引 5)
• Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group (2025 · Blood Advances · 被引 4)
• Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience (2025 · Hematological Oncology · 被引 3)
• Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis (2025 · Blood Advances · 被引 2)